Key terms
About OSA
Prosomnus, Inc. is a medical technology company, which engages in the business of developing, manufacturing, and marketing precision intraoral medical devices. It focuses on treating and managing patients with obstructive sleep apnea. The company was founded by Leonard Liptak and Sung Kim in 2006 and is headquartered in Pleasanton, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OSA news
Mar 28
2:03am ET
Prosomnus, Inc.: Navigating Market Volatility and Liquidity Risks Post-Merger
Mar 27
8:14am ET
ProSomnus price target lowered to 40c from $1 at Craig-Hallum
Mar 18
8:36am ET
Craig-Hallum Reaffirms Their Hold Rating on ProSomnus (OSA)
Feb 22
8:36am ET
ProSomnus reports pilot study validation of next generation RPM device
Feb 16
5:24pm ET
ProSomnus Faces Multiple Nasdaq Listing Compliance Issues
Jan 30
8:07am ET
ProSomnus announces FDA acceptance of 510(k) submission for EVO device
Jan 22
7:02am ET
ProSomnus initiated with a Buy at Alliance Global Partners
Jan 08
8:34am ET
ProSomnus comments on insurance coverage policy update
No recent press releases are available for OSA
OSA Financials
Key terms
Ad Feedback
OSA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OSA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
